Home
Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. Market Share Analysis for February 2026

Read our privacy policy to learn more about the information collected by our website, what we do and do not do with your information, and more.

Health > Biotechnology and Pharmaceuticals

Domainedgewisetx.com

Year Founded2017

Employees51 - 200

Annual Revenue--

Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. (including company regionals)

edgewisetx.com

See more website traffic and engagement information

Total visits to Edgewise Therapeutics, Inc.'s top domains

Understand Edgewise Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

edgewisetx.com6.7K

See more with Sales Intelligence

Avg. visit duration in Edgewise Therapeutics, Inc.'s top domains

Analyze Edgewise Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

edgewisetx.com00:00:30

See more with Sales Intelligence

Avg. pageviews on Edgewise Therapeutics, Inc.'s top domains

See how Edgewise Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

edgewisetx.com1.89

See more with Sales Intelligence

Edgewise Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Edgewise Therapeutics, Inc.

These are the website technologies, by industry, used by Edgewise Therapeutics, Inc. top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (6)

WooCommerce

Content Management System (5)

WordPress

Widget (4)

Twemoji

More Technologies

14

See all

News & Signals from Edgewise Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEdgewise Therapeutics, Inc. attends event Muscular Dystrophy Association 2026.Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference.

NewsEdgewise Therapeutics, Inc. attends event MDA Clinical and Scientific Conference 2026.At the MDA Clinical and Scientific Conference 2026, Edgewise Therapeutics presented results from the MESA open-label extension study, showing sustained functional stability in patients treated with sevasemten for up to 3.5 years.

NewsEdgewise Therapeutics, Inc. hires Nofi as chief accounting officer.Nofi joins Edgewise after serving as chief accounting officer at SpringWorks Therapeutics Inc., based in Stamford, Connecticut.